Discontinued — last reported Q2 '21

Current Assets

Net Cash Collateral Received - Derivative Instruments

Over 5 years (FY 2020 to FY 2025), Net Cash Collateral Received - Derivative Instruments shows a downward trend with a -100.0% CAGR.

Analysis

StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalContext dependent
VolatilityVolatile
First reportedQ3 2020
Last reportedQ2 2021

How to read this metric

Higher levels indicate increased derivative activity or a shift in the net credit risk position relative to counterparties.

Detailed definition

This represents the net balance of cash received from counterparties to secure derivative positions. It acts as a buffer...

Peer comparison

Common for firms heavily involved in hedging or trading derivative instruments.

Metric ID: net_cash_collateral_received_derivatives

Historical Data

19 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$0.00$0.00$0.00$0.00$0.00$0.00$19.00M$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$97.00M$0.00$0.00
QoQ Change-100.0%-100.0%
YoY Change-100.0%
Range$0.00$97.00M
Avg YoY Growth-100.0%
Median YoY Growth-100.0%

Net Cash Collateral Received - Derivative Instruments at Other Companies

Frequently Asked Questions

What is Merck & Co.'s net cash collateral received - derivative instruments?
Merck & Co. (MRK) reported net cash collateral received - derivative instruments of $0.00 in Q4 2025.
What is the long-term trend for Merck & Co.'s net cash collateral received - derivative instruments?
Over 5 years (2020 to 2025), Merck & Co.'s net cash collateral received - derivative instruments has grown at a -100.0% compound annual growth rate (CAGR), from $36.00M to $0.00.
What does net cash collateral received - derivative instruments mean?
The net amount of cash held by the company as security for derivative contracts.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.